These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37149104)

  • 61. The influence of consumers' preferences and perceptions of oral solid dosage forms on their treatment.
    Ibrahim IR; Ibrahim MI; Al-Haddad MS
    Int J Clin Pharm; 2012 Oct; 34(5):728-32. PubMed ID: 22744843
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Assessment of older adults' knowledge of and preferences for medication management tools and support systems.
    Lakey SL; Gray SL; Borson S
    Ann Pharmacother; 2009 Jun; 43(6):1011-9. PubMed ID: 19470855
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence of acceptability of oral paediatric medicines: a review.
    Mistry P; Batchelor H;
    J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 3D printing in the design of pharmaceutical dosage forms.
    Souto EB; Campos JC; Filho SC; Teixeira MC; Martins-Gomes C; Zielinska A; Carbone C; Silva AM
    Pharm Dev Technol; 2019 Oct; 24(8):1044-1053. PubMed ID: 31180272
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review.
    Yourman L; Concato J; Agostini JV
    Am J Geriatr Pharmacother; 2008 Jun; 6(2):119-29. PubMed ID: 18675770
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Buccal Dosage Forms: General Considerations for Pediatric Patients.
    Montero-Padilla S; Velaga S; Morales JO
    AAPS PharmSciTech; 2017 Feb; 18(2):273-282. PubMed ID: 27301872
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pediatric drug formulations: a review of challenges and progress.
    Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
    Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Basics of compounding foam dosage forms.
    Allen LV
    Int J Pharm Compd; 2013; 17(4):312-22. PubMed ID: 24261147
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Consensus guidelines for oral dosing of primarily renally cleared medications in older adults.
    Hanlon JT; Aspinall SL; Semla TP; Weisbord SD; Fried LF; Good CB; Fine MJ; Stone RA; Pugh MJ; Rossi MI; Handler SM
    J Am Geriatr Soc; 2009 Feb; 57(2):335-40. PubMed ID: 19170784
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Paediatric specific dosage forms: Patient and formulation considerations.
    Khan D; Kirby D; Bryson S; Shah M; Rahman Mohammed A
    Int J Pharm; 2022 Mar; 616():121501. PubMed ID: 35092832
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oral dosage forms and drug delivery systems: tablets, oral films, liquid dosage forms, oral bioavailability enhancement.
    Alany R
    Pharm Dev Technol; 2017 Mar; 22(2):137. PubMed ID: 28178908
    [No Abstract]   [Full Text] [Related]  

  • 72. Polypharmacy in older adults: Association Rule and Frequent-Set Analysis to evaluate concomitant medication use.
    Held F; Le Couteur DG; Blyth FM; Hirani V; Naganathan V; Waite LM; Seibel MJ; Handelsman DJ; Cumming RG; Allore HG; Gnjidic D
    Pharmacol Res; 2017 Feb; 116():39-44. PubMed ID: 27988385
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of high-risk medications on mortality risk among older adults with polypharmacy: evidence from the English Longitudinal Study of Ageing.
    Huang YT; Steptoe A; Wei L; Zaninotto P
    BMC Med; 2021 Dec; 19(1):321. PubMed ID: 34911547
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements.
    Cilurzo F; Musazzi UM; Franzé S; Selmin F; Minghetti P
    Drug Discov Today; 2018 Feb; 23(2):251-259. PubMed ID: 29030242
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies.
    Gioumouxouzis CI; Karavasili C; Fatouros DG
    Drug Discov Today; 2019 Feb; 24(2):636-643. PubMed ID: 30503803
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methodology Used to Assess Acceptability of Oral Pediatric Medicines: A Systematic Literature Search and Narrative Review.
    Mistry P; Batchelor H;
    Paediatr Drugs; 2017 Jun; 19(3):223-233. PubMed ID: 28413843
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study.
    Ranmal SR; Cram A; Tuleu C
    Int J Pharm; 2016 Nov; 514(1):296-307. PubMed ID: 27863675
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD.
    Surana S; Kumar N; Vasudeva A; Shaikh G; Jhaveri KD; Shah H; Malieckal D; Fogel J; Sidhu G; Rubinstein S
    BMC Nephrol; 2017 Jan; 18(1):26. PubMed ID: 28095816
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Basics of Compounding: Clinical Pharmaceutics, Part 2.
    Allen LV
    Int J Pharm Compd; 2016; 20(6):485-493. PubMed ID: 28339388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.